Jump to any asset
850 assets, updated daily
As of September 11, 2026, Illumina Inc. (ILMN) trades at $206.28. CleaRank Financial AI rates it Hold with a fair value of $206.28, in line with the current price. Wall Street's consensus target is $213.00 across 20 analysts. RSI at 41 is in neutral territory, and the price is above its 50-day average of $200.30.
Illumina Inc. (ILMN)
Illumina Inc. NASDAQ
$206.28
5.010 (2.49%)
Latest Price
AI Analyst Consensus
59 / 100
Illumina Inc. is currently trading at $206.28, with its price action showing a neutral momentum as indicated by an RSI of 40.5. The stock is positioned above its 50-day and 200-day moving averages ($200.30 and $153.56), suggesting some underlying support, but is trading below its 20-day EMA. The company's recent earnings report for July 2026 showed a significant miss, with an EPS of -0.02 against an estimate of 0.04, resulting in a -150% surprise and a 1.84% price drop. This follows a pattern of mixed earnings performance, with a strong beat in April 2026 and a substantial beat in February 2026. Despite a consensus rating of Hold from Wall Street analysts, with a median price target of $213 implying a limited 3.3% upside, the most significant concern is the heavy insider selling. Insiders have sold over $592 million in the past, far outweighing the $1.6 million in purchases, leading to a 'Heavy Sell Signal' verdict. This substantial divestiture by management and key personnel raises questions about their confidence in the company's near-to-medium term prospects, even as revenue growth is projected to be around 6% for the current and next year.
ILMN Price Analysis
Market Metrics
Open
$202.49
Day Range
$200.46 to $208.38
Prev Close
$201.27
Volume
39.9K
52-Week Range
$88.00 to $231.81
Market Cap
$30.39B
Peer Benchmarking
Valuation vs Sector (Healthcare)
Performance vs XLV
Sector Position Analysis
Trading at a significant premium to sector peers (+48%), suggesting market expectations for superior growth or market position.
ILMN Analysis
Company's Health
3/5
12-Month Analyst Target
+3.26% Upside
Median of 20 analysts (12-month)
$213.00
AI Technical Analysis
Illumina Inc.'s trading volume has been exceptionally low, registering at 398,690, which is a stark 97.4% below its average volume of 1,540,647. This low volume suggests a lack of conviction from market participants regarding the current price action. The stock is trading above its 50-day and 200-day moving averages ($200.30 and $153.56), indicating a generally upward long-term trend, but it is currently below its 20-day exponential moving average, pointing to short-term weakness. The Relative Strength Index (RSI) is at 40.5, which falls into the neutral momentum category, suggesting neither overbought nor oversold conditions. Key support levels are likely to be found around the 50-day SMA of approximately $200.30, while resistance may be encountered near the 20-day EMA at around $209.01. The stochastic oscillator is at 18.56, indicating a position closer to oversold territory, which could suggest a potential for a short-term bounce, but this is not confirmed by the RSI. The Commodity Channel Index (CCI) at -106.85 also points towards bearish momentum in the short term.
ProTips
- Given the 'Heavy Sell Signal' from insiders, investors should closely monitor any further disclosures of insider transactions and consider the implications for management's confidence in the company's future prospects.
- The extremely low trading volume suggests a lack of market conviction; consider waiting for increased volume or clearer technical signals before initiating or adding to a position.
- With a P/E ratio significantly above the sector average and recent earnings misses, risk-averse investors may want to wait for a more attractive entry point or clearer signs of fundamental improvement.
Key Catalysts
Bearish
Heavy Insider Selling Pressure
Insiders have sold over $592 million in stock, far exceeding the $1.6 million in purchases, resulting in a 'Heavy Sell Signal' and raising concerns about management's confidence.
Source: Insider Transactions DataBearish
Recent EPS Miss and Negative Surprise
The latest earnings report for July 2026 showed an EPS of -0.02 against an estimate of 0.04, a -150% surprise, leading to a price decline and highlighting execution challenges.
Source: Earnings ReportNeutral
Neutral Technical Momentum
The RSI is at 40.5, indicating neutral momentum, and the stock is trading below its 20-day EMA, suggesting a lack of immediate bullish technical signals.
Source: Technical AnalysisNeutral
Modest Revenue Growth Projections
Revenue growth is projected to be around 6% for the current and next fiscal years, which may not be sufficient to justify the current premium valuation.
Source: Wall Street Revenue EstimatesMarket Outlook
The base case for Illumina Inc. over the next 6-12 months is cautious, given the significant insider selling and a premium valuation that is not fully supported by recent earnings performance or projected growth rates. While the stock is trading above key long-term moving averages, the neutral technical momentum and extremely low volume suggest a lack of immediate catalysts for a significant upward move. The median analyst price target of $213 implies only a marginal upside from the current price of $206.28. Potential upside could materialize if the company demonstrates a consistent return to strong earnings beats and if insider selling subsides, signaling renewed confidence. Conversely, continued earnings misses, a failure to accelerate revenue growth beyond the projected 6%, or further negative news regarding competitive pressures or regulatory scrutiny could pressure the stock lower, potentially testing the support around the 50-day SMA near $200.30.
Key Statistics
| Market Cap | 30.39B |
|---|---|
| P/E Ratio | 37.62 |
| EPS (TTM) | 5.35 |
| Dividend Yield | 0.00% |
| 52 Week High | 231.81 |
| 52 Week Low | 88.00 |
Illumina Inc. exhibits a Price-to-Earnings (P/E) ratio of 37.62, which is considerably higher than the sector average P/E of 25.5, suggesting the stock is trading at a premium relative to its peers. The Earnings Per Share (EPS) stands at $5.35. While the company's revenue growth is projected at approximately 6% for both the current and next fiscal years, this growth rate appears modest when compared to its elevated valuation multiples. The balance sheet strength is not explicitly detailed with debt-to-equity or cash figures, but the P/E ratio suggests that investors are pricing in significant future growth. The company's recent earnings performance, particularly the negative EPS surprise in the latest quarter, raises concerns about profitability execution. The premium valuation, coupled with mixed earnings and substantial insider selling, creates a risk-reward scenario that warrants careful consideration.
Earnings & Growth Analysis
Illumina Inc.'s most recent earnings report for the quarter ending July 2026 revealed a significant miss, with an actual EPS of -0.02 compared to an estimated 0.04, translating to a -150% surprise and a 1.84% decline in stock price. This follows a period of mixed performance, including a strong beat in April 2026 (1.15 actual vs. 1.05 estimate) and a substantial beat in February 2026 (0.43 actual vs. 0.16 estimate). The current revenue growth is estimated at 6.00% for the current quarter and 5.00% for the next quarter, indicating a slowdown in top-line expansion.
Key Risks
The primary risk for Illumina Inc. is the significant insider selling, with over $592 million in sales against only $1.6 million in purchases, signaling a 'Heavy Sell Signal' from management. This heavy divestiture raises concerns about internal confidence in future performance. Additionally, the stock's P/E ratio of 37.62 is substantially higher than the sector average of 25.5, indicating a potentially overvalued stock given recent earnings misses and modest projected revenue growth. The neutral technical momentum, with an RSI of 40.5 and the stock trading below its 20-day EMA, suggests a lack of immediate upward catalysts.
Technical Indicators
| RSI (14) | 40.50 |
|---|---|
| MACD | 2.93 |
| SMA 50 | 200.30 |
| SMA 200 | 153.56 |
RSI
Neutral
SMA Cross
Bullish
Price vs SMA
Bullish
MACD
Bullish
Golden Cross in effect with the 50-day SMA ($200.30) above the 200-day SMA ($153.56), price action is firmly bullish above key moving averages.
Market Correlations
How this stock moves relative to other assets
Based on 1 year of daily price data. Correlations may vary over different time periods.
S&P 500 (SPY)
+0.38
Weak correlation
Nasdaq 100 (QQQ)
+0.34
Weak correlation
Bitcoin (BTC)
+0.27
Weak correlation
Gold (XAU)
+0.07
Weak correlation
Check Custom Correlation
Calculating correlation...
ILMN Trade Plans
Specific entry, exit, and risk management levels
Select Your Trade Bias
Risk Tolerance
Conservative
2%
Aggressive
Portfolio Value
$
Position Size: Enter portfolio size →
Entry Strategies (click to switch)
CONSERVATIVE
$204.22
Slight discount to current
Wait for small dip
AGGRESSIVE
$206.28
At current price
Enter now if confident
Risk Management
STOP LOSS
$192.11
MAX LOSS
-5.9%
Volatility-Adjusted Stop Loss
Calculated based on RSI (40.5) and current market volatility
Profit Targets (Based on Conservative Entry)
TARGET 1
$210.34
+3% (Conservative)
+2.0% (Aggressive)
TARGET 2
$214.43
+5% (Conservative)
+3.9% (Aggressive)
TARGET 3
$220.55
+8% (Conservative)
+6.9% (Aggressive)
Consider scaling out: Take 50% profit at Target 1, 30% at Target 2, let 20% run to Target 3
Calculate Your Trade
Disclaimer
This AI-generated trade plan for ILMN is for educational and informational purposes only and does not constitute financial advice. The analysis is based on historical data patterns and technical indicators which may not predict future results. Stock trading involves risk of loss. Verify all data independently and consult a qualified financial advisor. Generated on September 11, 2026.Growth of $10,000
A $10,000 investment in ILMN in September 2016 would be worth about $12,120 today, compared with about $35,030 for the same investment in the S&P 500 benchmark.
Compare with Another Ticker
Monte Carlo Projection (10yr)
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in ILMN today could grow to about $15,235 by 2036 in the base case, with a bull case near $85,148 and a bear case around $2,726. Projections are statistical simulations, not guarantees.
ILMN Stock Price Prediction: 2030
CleaRank's simulation projects a price near $244 for ILMN by 2030 in the base case, from $206 today (1.2x over 4 years). The downside path ends near $82.21. These are outcomes of a Monte Carlo simulation run on ILMN's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | Downside (10th pct) | Base case | Upside (90th pct) |
|---|---|---|---|
| 2027 | $125 | $215 | $371 |
| 2028 | $104 | $224 | $484 |
| 2029 | $91.20 | $234 | $601 |
| 2030 | $82.21 | $244 | $725 |
| 2031 | $75.41 | $255 | $860 |
| 2032 | $70.03 | $266 | $1,007 |
| 2033 | $65.64 | $277 | $1,169 |
| 2034 | $61.99 | $289 | $1,346 |
| 2035 | $58.89 | $301 | $1,542 |
| 2036 | $56.23 | $314 | $1,756 |
Method: 10,000 simulated price paths using ILMN's historical volatility and drift, re-run daily. The base case is the median path; the two outer columns are the 10th and 90th percentile outcomes, which widen with time because uncertainty compounds. Simulations are not guarantees, and past volatility does not predict future returns. This is analysis, not investment advice.
People Also Watch
ILMN Insider Trading Analysis
Bought
$1.6M
4 Transactions
Sold
$592.9M
18 Transactions
Insiders
22
Active Traders
Avg Transaction
$27.0M
Large trades
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Aug 5, 2026 | MEISTER KEITH A
Director
|
Sell | 741.1K | $148.2M |
| Aug 21, 2026 | MEISTER KEITH A
Director
|
Sell | 679.6K | $145.6M |
| Jun 1, 2026 | MEISTER KEITH A
Director
|
Sell | 669.6K | $107.0M |
| Aug 27, 2026 | MEISTER KEITH A
Director
|
Sell | 375.9K | $85.2M |
| Sep 4, 2026 | MEISTER KEITH A
Director
|
Sell | 263.6K | $57.2M |
| May 14, 2026 | MEISTER KEITH A
Director
|
Sell | 329.5K | $47.9M |
| Feb 16, 2021 | FLATLEY JAY T
Director
|
Sell | 4.5K | $2.3M |
| Feb 2, 2021 | FLATLEY JAY T
Director
|
Sell | 4.0K | $1.8M |
| Mar 2, 2021 | FLATLEY JAY T
Director
|
Sell | 4.0K | $1.8M |
| Aug 31, 2020 | RAGUSA ROBERT P
Officer
|
Sell | 5.0K | $1.8M |
Page 1 of 1
Frequently Asked Questions
What is Illumina Inc.'s current stock price and consensus rating?
Illumina Inc. is currently trading at $206.28 per share. The consensus rating among Wall Street analysts is 'Hold', with a consensus score of 59 out of 100.
What is the median analyst price target for Illumina Inc. stock?
The median analyst price target for Illumina Inc. is $213.00, suggesting a potential upside of 3.3% from the current stock price of $206.28.
What are the key risks facing Illumina Inc.?
The most significant risk is the heavy insider selling, totaling over $592 million, which indicates a lack of confidence from management. The stock also trades at a premium valuation with a P/E ratio of 37.62 compared to the sector average of 25.5, and has shown mixed recent earnings performance.
How has Illumina Inc. performed in its recent earnings reports?
Illumina Inc. reported a significant EPS miss in its most recent quarter ending July 2026 (-0.02 actual vs. 0.04 estimate), resulting in a -150% surprise. Prior quarters showed mixed results with both beats and misses.
What is the technical outlook for Illumina Inc. stock?
Technically, Illumina Inc. shows neutral momentum with an RSI at 40.5. While the stock is above its 50-day and 200-day moving averages ($200.30 and $153.56), it is below its 20-day EMA, and trading volume is exceptionally low, suggesting a lack of strong conviction.
How does Illumina Inc.'s valuation compare to its sector averages?
Illumina Inc.'s P/E ratio of 37.62 is notably higher than the sector average of 25.5, indicating that the stock is trading at a premium. Projected revenue growth for the current and next year is around 6%.
What does the insider transaction data suggest about Illumina Inc.?
Insider transaction data reveals a 'Heavy Sell Signal,' with insiders selling over $592 million in stock compared to only $1.6 million in purchases. This significant net selling activity is a key concern for investors.